ARS Pharmaceuticals Dirección
Dirección controles de criterios 2/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Rich Lowenthal
Chief Executive Officer (CEO)
US$10.0m
Compensación total
| Porcentaje del salario del CEO | 6.2% |
| Permanencia del CEO | 2yrs |
| Participación del CEO | 5.8% |
| Permanencia media de la dirección | 2.6yrs |
| Promedio de permanencia en la Junta Directiva | 3.3yrs |
Actualizaciones recientes de la dirección
Recent updates
ARS Pharmaceuticals: Demand Curve Is Key Unknown
Nov 20We're Interested To See How ARS Pharmaceuticals (NASDAQ:SPRY) Uses Its Cash Hoard To Grow
Sep 13
ARS Pharmaceuticals: A Decent Bet For Upside After Neffy Approval
Sep 06ARS Pharmaceuticals On Track With Neffy Despite Regulatory Hurdles
Jun 25We're Not Very Worried About ARS Pharmaceuticals' (NASDAQ:SPRY) Cash Burn Rate
Mar 18ARS Pharmaceuticals (NASDAQ:SPRY) Is In A Good Position To Deliver On Growth Plans
Nov 14Here's Why We're Not Too Worried About ARS Pharmaceuticals' (NASDAQ:SPRY) Cash Burn Situation
May 12Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$49m |
| Jun 30 2024 | n/a | n/a | -US$45m |
| Mar 31 2024 | n/a | n/a | -US$50m |
| Dec 31 2023 | US$10m | US$620k | -US$54m |
| Sep 30 2023 | n/a | n/a | -US$62m |
| Jun 30 2023 | n/a | n/a | -US$53m |
| Mar 31 2023 | n/a | n/a | -US$42m |
| Dec 31 2022 | US$909k | US$75k | -US$35m |
Compensación vs. Mercado: La compensación total de Rich($USD10.04M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD5.37M).
Compensación vs. Ingresos: La compensación de Rich ha aumentado mientras la empresa no es rentable.
CEO
Rich Lowenthal (58 yo)
2yrs
Permanencia
US$10,039,096
Compensación
Mr. Richard E. Lowenthal, also known as Rich, MS, MSEL, MBA, He serves as Director, Chief Executive Officer & President at ARS Pharmaceuticals, Inc. since November 08, 2022. He served as Head of Regulatory...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Founder | 2yrs | US$10.04m | 5.77% $ 76.0m | |
| Co-Founder & Chief Medical Officer | no data | US$4.79m | 3.51% $ 46.2m | |
| Chief Legal Officer & Secretary | 1.8yrs | US$5.32m | 0.092% $ 1.2m | |
| Co-Founder & Chief Science Officer | no data | sin datos | 4.34% $ 57.1m | |
| Chief Financial Officer | 2.6yrs | sin datos | 0.014% $ 178.8k | |
| Chief Operations Officer | no data | sin datos | 0.0062% $ 81.6k | |
| Senior Vice President of Marketing | 2.8yrs | sin datos | sin datos | |
| Executive Vice President of Commercial Strategy | 2.8yrs | sin datos | sin datos | |
| Chief Commercial Officer | 2.6yrs | US$618.61k | 0.0059% $ 77.2k | |
| Chief Business Officer & Secretary | 2yrs | sin datos | sin datos |
2.6yrs
Permanencia media
55yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de SPRY se considera experimentado (2.6 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Founder | 2yrs | US$10.04m | 5.77% $ 76.0m | |
| Independent Director | no data | US$261.30k | 0% $ 0 | |
| Chairman of the Board | no data | US$508.80k | 4.96% $ 65.4m | |
| Director | 3.5yrs | US$238.80k | 0% $ 0 | |
| Independent Director | 3.3yrs | US$256.30k | sin datos | |
| Independent Director | 3.3yrs | US$253.80k | sin datos | |
| Independent Director | 2yrs | US$250.05k | 0.016% $ 206.5k | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Independent Director | no data | US$248.80k | 0.086% $ 1.1m | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos |
3.3yrs
Permanencia media
54yo
Promedio de edad
Junta con experiencia: La junta directiva de SPRY se considera experimentada (3.3 años de antigüedad promedio).